Auxly Subsidiary Dosecann Partners With Medical Cannabis By Shoppers

Auxly Cannabis Group Inc. (TSX.V:XLY) CBWTF reported Wednesday that its subsidiary Dosecann LD Inc. has signed a supply agreement with Medical Cannabis by Shoppers Drug Mart’s online medical cannabis platform.

In this manner, Dosecann will supply cannabis products via the platform, making a plethora of its products and brands accessible to Canadian consumers.

The products include chocolates, oils, chewables, and vapes.

The deal has a three-year term, with an option for an extension of an extra two years.

“Having our diverse cannabis product offering with Shoppers allows us to reach a wide group of patients across the country with our quality, science-backed products,” Auxly CEO Hugo Alves said in a statement. “We are proud to partner with Shoppers and look forward to bringing their customers our products, built on Dosecann’s pillars of quality, safety and efficacy.”

Dosecann, a wholly-owned subsidiary of Auxly, produces original cannabis products with wellness features.

Auxly is an international cannabis company founded in 2017, which offers a variety of premium and original cannabis products, covering medical, adult-use and wellness markets. Recently, it has announced obtaining exclusive rights to omega-rich Ahiflower seed oil for use in its products, and several management changes.

Auxly’s shares were trading 1.04% higher at 28 cents per share on Thursday morning.

Related Links:

Cannabis 2.0: The Companies Entering Canada's New Edible, Concentrate, Topical Market

Analyst Dives Into Cannabis 2.0, Says There Are Fewer Suppliers And A More Concentrated Market

Photo courtesy of Auxly

 

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsMarketscannabis industrycannabis sales
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
Cannabis Conference Chicago 2024

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.